TKO heads into the back half of August with an uncomfortable story at the executive level: the CEO, CFO, COO, and several vice presidents have all sold stock in the past five weeks, even as the share price trades 22% higher than a month ago.
The insider selling is the dominant signal this week. CEO Stuart McDonald alone sold 200,000 shares across two transactions on August 10 and August 12, collecting roughly CAD 2.5 million. CFO Bryce Hamming sold 25,000 shares on August 10. The COO sold 100,000 shares in mid-July. In total, net insider selling over the past 90 days amounts to more than 650,000 shares, worth roughly USD 5.5 million. Every recent trade is a sale — there is no balancing buyer among the named insiders — and the cluster covers five different officers spanning the C-suite and vice president level.
The lending market offers little reason to worry from a short-seller perspective, and that makes the insider activity stand out more sharply. Short interest is negligible at just 0.85% of the free float, down nearly 46% over the past month as shorts have unwound positions into the rally. Availability is exceptionally loose — more than 5,000% of current short interest is available to borrow — meaning the lending pool is essentially untapped. Cost to borrow has edged higher over the past week, up around 32% to 1.57%, but remains low in absolute terms. There is no borrow squeeze here, no short-side pressure building: the positioning picture is benign, almost unusually so for a stock that has moved this sharply.
The valuation tells a complicated story. The PE multiple has expanded materially over the past month, rising roughly 2 points to 12.5x — modest on its face, but the factor scores reveal the tension. The forward EPS growth rank sits in the 95th percentile of the universe, one of the strongest growth signals available, while the short score rank at 85 reflects very low short-side conviction. Yet the EPS surprise score ranks only in the 32nd percentile, suggesting the market has been pricing in the growth story faster than actual results have confirmed it. The EV/EBITDA multiple at 6.8x is relatively contained, and the enterprise value prints at roughly CAD 4.8 billion, but with no analyst consensus data available to cross-check, the valuation picture carries some uncertainty.
Peers are broadly weaker this week. NGEX fell 4% and HBM dropped 4.7%. AYA and ERO were the hardest hit, down 10.4% and 9.2% respectively. TKO's 5.5% weekly decline tracks broadly with the sector move, so the price action is not obviously idiosyncratic — but the insider pattern predates this week's softness, with the heaviest selling occurring while the stock was trading near CAD 12.
The next earnings event is slated for November 2. Between now and then, the question worth tracking is whether the pace of insider selling continues at current prices, or whether it slows as the stock gives back more of its one-month gain.
See the live data behind this article on ORTEX.
Open TKO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
